Chinese Journal of Arteriosclerosis (CN 43-1262/R, ISSN 1007-3949) is a professional academic journal governed by China Association for Science and Technology and sponsored by Chinese Association of Pathophysiology and University of South China. The publishing scope of the journal includes the prevention and treatment of arteriosclerotic diseases (such as hyperlipidemia, coronary artery disease, ischemic cerebrovascular disease, hypertension, arteriosclerosis and other ischemic diseases) in traditional Chinese medicine, preventive medicine, basic medicine, clinical medicine, pharmacology and special medicine. The columns include original research article (including epidemiological research, experimental research, clinical research and methodological research), review, diagnosis and treatment experience, case report, lectures, etc. The aim of the journal is to report cutting-edge theories, viewpoints, therapies and new drugs for the prevention and treatment of arteriosclerotic diseases, introduce new experience and knowledge of prevention and control, facilitate academic research and promote academic exchanges at home and abroad, and promote the improvement of human health.
Chinese Journal of Arteriosclerosis was selected as the core journal of the 2014 edition of Chinese Core Journals Catalog. The Journal was rated as RCCSE Chinese Core Academic Journal in the Chinese Academic journals Evaluation Report (2009-2010). The journal is also indexed by the Statistical Source of Chinese Scientific and Technological Papers (China Scientific and Technological Core Journal) of the Ministry of Science and Technology, Chemical Abstract (CA), Russian Abstract Journal (AJ), Wanfang Data, Chinese Academic Journals (CNKI) and other well-known retrieval databases.